In another interview from the Road to 2021 road trip campaign, Russel Harris, CCO of Centaur Biopharmaceutical Services, speaks with Nigel about how COVID-19 transformed the biopharmaceutical supply chain.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
Centaur offers end-to-end biologics services, including cell line development, master cell banking, process development, assay development, stability testing, and cGMP clinical and commercial manufacturing from 50L to 2,000L.
.svg)
